UK – Plethora Solutions Holdings plc (AIM: PLE) announces that it has strengthened the board with the appointment of Dr Greg Bailey and Mike Collis as non-executive directors with immediate effect.
About Greg Bailey
Dr Bailey is an investor and entrepreneur in the biomedical sector having spent time previously as an investment banker and a physician. He is currently a Co-Chairman of Topix Pharma, Inc. and Chairman of Portage Biotech , Inc. He is the managing partner of Palantir Group, Inc., a biotech merchant bank. Dr Bailey has arranged and participated in multiple financings, M&A transactions, and taken a number of companies public. He personally co-founded or funded three companies currently valued at over 5 billion dollars including Medivation, Inc., the recently acquired Ascent Healthcare Solutions and VirnetX Inc. He has been a board member of several public companies. Dr. Bailey practiced emergency medicine for 10 years.
About Mike Collis
Mike Collis is an advisor to Maven Capital Partners LLP (“Maven”), which manages the Capital for Enterprise Fund (“CfE”). CfE provided a £1m facility to the Company under which it has the right to appoint a director to the board. Mr Collis is a specialist in financial turnarounds and is a member of the Institute for Turnaround and also a Chartered Accountant. He is managing director of Arc Portfolio Management Limited. He was previously Head of Portfolio Management at Aberdeen Asset Managers Private Equity. He has served on the boards of a number of private companies often as a nominee of the investor. Mr Collis qualified as a Chartered Accountant with Arthur Andersens.
Jim Mellon, Chairman of Plethora said: “I am delighted to welcome Greg and Mike to the Board. They add significant experience at a time when the Company is poised to achieve long-awaited milestones in terms of approval and commercialization of PSD 502. Plethora is on the verge of an exciting future and it is appropriate that we add the highest calibre people to our Board to guide the business to profitability.”
About Plethora
Plethora is headquartered in the UK and is listed on the London Stock Exchange (AIM: PLE.L).
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
